Breaking News: Aadi Bioscience Shares Exciting Updates on Precision1 Trial and Corporate Progress

Aadi Bioscience Halts Tumor-Agnostic Trial and Shifts Focus to FYARRO® Commercial Business LOS ANGELES , Aug. 20, 2024 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating alterations. An analysis by the Independent Data Monitoring Committee…

Read More

Revolutionizing Crop Protection: FMC Corporation Takes Global Action with Dodhylex Active – Submitting Regulatory Applications in Eight Countries!

FMC Corporation Introduces New Herbicide Dodhylex™ for Rice Growers PHILADELPHIA, Aug. 20, 2024 /PRNewswire/ — FMC Corporation, a leading agricultural sciences company, has unveiled a groundbreaking new herbicide for rice farmers. The introduction of Dodhylex™ marks the first new mode of action herbicide in over 30 years, offering a significant breakthrough in weed management. With…

Read More

Uncovering Coloplast’s Q3 2024 Earnings Call: A Deep Dive into the Heart of the Company’s Financial Performance

Welcome to the Coloplast Q3 2024 Earnings Conference Call Embracing Change and Growth As the sun rises on August 20, 2024, the Coloplast team gathers for the highly anticipated Q3 earnings conference call. The air is filled with excitement and anticipation as President and CEO Kristian Villumsen and CFO Anders Lonning-Skovgaard lead the charge in…

Read More